Suppliers / ORIL Industrie

ORIL Industrie

France Updated 9 July 2026

ORIL Industrie is an API manufacturer based in France. It holds one active US drug master file and 4 valid CEPs across a filed portfolio of 7 molecules. Its GMP standing is certified by ANSM (FR). Its most recent recorded inspection, by US FDA, closed on 6 April 2023 as VAI.

1
active US DMFs
4
valid CEPs
4
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 April 2023 VAI US FDA
  • 14 September 2018 VAI US FDA
  • 17 October 2014 VAI US FDA
  • 9 December 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
BOLBEC, France Not on file
BOLBEC, France Not on file
France, France 1000435915
Bolbec, France Not on file

What they file, and where

Molecule Regulators Docs
Gliclazide EDQM, SFDA (Saudi Arabia) 2
Indapamide EDQM, SFDA (Saudi Arabia) 2
Ivabradine SFDA (Saudi Arabia), US FDA 2
Perindopril SFDA (Saudi Arabia) 2
Atorvastatin SFDA (Saudi Arabia) 1
Perindopril Tert-Butylamine EDQM 1
Rilmenidine Dihydrogen Phosphate EDQM 1

Also appears on these molecule pages

Gliclazide API Indapamide API Ivabradine API Perindopril API Perindopril Tert-Butylamine API Atorvastatin API

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) None 50

Questions about ORIL Industrie

Does ORIL Industrie hold a US DMF or a CEP?
ORIL Industrie holds 1 active US drug master file and 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is ORIL Industrie FDA-registered?
One site operated by ORIL Industrie carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did ORIL Industrie's last inspection go?
The most recent inspection on record closed on 6 April 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does ORIL Industrie manufacture?
4 registered sites are on record, in France (Bolbec, France and Bolbec among others). Every site is listed on this page with the register it came from.
What does ORIL Industrie make?
7 molecules are on record against ORIL Industrie, including Gliclazide, Indapamide, Ivabradine and Perindopril. Each links through to that molecule's full manufacturer list.
Which regulators recognise ORIL Industrie's GMP?
Current GMP certificates are on record from ANSM (FR). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. ORIL Industrie comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 April 2023.

Comparable suppliers

Apitoria Pharma shares 2 molecules Hetero shares 2 molecules Alivus Life Sciences shares 2 molecules Zhejiang Huahai Pharmaceutical shares 2 molecules Piramal Pharma shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates